Variant report

Variant	nsv826294
Chromosome Location	chr12:29934604-29940372
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:281)
CpG islands
(count:916)
Chromatin interactive
region (count:0)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:281 , 50 per page) page: 1 2 3 4 5 6

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF2	chr12:29934883-29935429	GM12878	blood:	n/a	n/a
2	BACH1	chr12:29935121-29936543	H1-hESC	embryonic stem cell:	n/a	n/a
3	BACH1	chr12:29937171-29937398	H1-hESC	embryonic stem cell:	n/a	n/a
4	BATF	chr12:29935114-29935428	GM12878	blood:	n/a	chr12:29935271-29935282
5	BATF	chr12:29935060-29935434	GM12878	blood:	n/a	chr12:29935271-29935282
6	BHLHE40	chr12:29934973-29935602	GM12878	blood:	n/a	n/a
7	BRCA1	chr12:29935046-29935696	Hela-S3	cervix:	n/a	n/a
8	CEBPB	chr12:29935242-29935718	IMR90	lung:	n/a	n/a
9	CEBPB	chr12:29936014-29936218	H1-hESC	embryonic stem cell:	n/a	n/a
10	CEBPB	chr12:29935213-29936304	Hela-S3	cervix:	n/a	n/a
11	CEBPB	chr12:29935351-29935608	ECC-1	luminal epithelium:	n/a	n/a
12	CEBPB	chr12:29935428-29935638	HepG2	liver:	n/a	n/a
13	CHD1	chr12:29934973-29937715	IMR90	lung:	n/a	chr12:29936887-29936897
14	CHD1	chr12:29935672-29936902	H1-hESC	embryonic stem cell:	n/a	chr12:29936887-29936897
15	CHD2	chr12:29935989-29936421	Hela-S3	cervix:	n/a	n/a
16	CHD2	chr12:29937259-29937298	H1-hESC	embryonic stem cell:	n/a	n/a
17	CHD2	chr12:29936959-29937008	H1-hESC	embryonic stem cell:	n/a	n/a
18	CHD2	chr12:29936639-29937431	Hela-S3	cervix:	n/a	chr12:29936887-29936897
19	CHD2	chr12:29935116-29935740	Hela-S3	cervix:	n/a	n/a
20	CTBP2	chr12:29935729-29936977	H1-hESC	embryonic stem cell:	n/a	n/a
21	CTCF	chr12:29936475-29936614	MCF-7	breast:	n/a	n/a
22	CTCF	chr12:29936420-29936570	HPAF	blood vessel:	n/a	n/a
23	CTCF	chr12:29936432-29936601	A549	lung:	n/a	n/a
24	CTCF	chr12:29936400-29936550	NHDF-neo	bronchial:	n/a	n/a
25	CTCF	chr12:29936400-29936550	AG04449	skin:	n/a	n/a
26	CTCF	chr12:29936484-29936581	GM19239	blood:	n/a	n/a
27	CTCF	chr12:29936440-29936590	BJ	skin:	n/a	n/a
28	CTCF	chr12:29936440-29936590	NHEK	skin:	n/a	n/a
29	CTCF	chr12:29936529-29936537	Hela-S3	cervix:	n/a	n/a
30	CTCF	chr12:29936340-29936490	HEK293	kidney:	n/a	n/a
31	CTCF	chr12:29936494-29936593	Gliobla	brain:	n/a	n/a
32	CTCF	chr12:29936360-29936510	HUVEC	blood vessel:	n/a	n/a
33	CTCF	chr12:29937460-29937610	HUVEC	blood vessel:	n/a	n/a
34	CTCF	chr12:29937300-29937450	HBMEC	blood vessel:	n/a	n/a
35	CTCF	chr12:29937200-29937350	SK-N-SH_RA	brain:	n/a	n/a
36	CTCF	chr12:29936340-29936490	HCM	heart:	n/a	n/a
37	CTCF	chr12:29936444-29936592	HepG2	liver:	n/a	n/a
38	CTCF	chr12:29936460-29936616	NHEK	skin:	n/a	n/a
39	CTCF	chr12:29936422-29936607	MCF-7	breast:	n/a	n/a
40	CTCF	chr12:29936495-29936601	MCF-7	breast:	n/a	n/a
41	CTCF	chr12:29936400-29936550	HRE	kidney:	n/a	n/a
42	CTCF	chr12:29936400-29936550	WERI-Rb-1	eye:	n/a	n/a
43	CTCF	chr12:29936400-29936550	HUVEC	blood vessel:	n/a	n/a
44	CTCF	chr12:29936400-29936550	HCPEpiC	choroid plexus:	n/a	n/a
45	CTCF	chr12:29936482-29936587	Fibrobl	skin:	n/a	n/a
46	CTCF	chr12:29936440-29936590	HMEC	breast:	n/a	n/a
47	CTCF	chr12:29936420-29936570	SAEC	small airway:	n/a	n/a
48	CTCF	chr12:29936502-29936575	MCF-7	breast:	n/a	n/a
49	CTCF	chr12:29936479-29936593	GM19238	blood:	n/a	n/a
50	CTCF	chr12:29936423-29936675	GM12878	blood:	n/a	n/a

(count:916 , 50 per page) page: 1 2 3 4 5 6 7 ... 19

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr12:29936174-29936224	HAEpiC	amniotic membrane:	n/a
2	chr12:29936174-29936224	HAEpiC	amniotic membrane:	n/a
3	chr12:29936125-29936175	A549	lung:	n/a
4	chr12:29936486-29936536	HUVEC	blood vessel:	n/a
5	chr12:29936845-29936895	Caco-2	colon:	n/a
6	chr12:29936174-29936224	Hepatocyte	liver:	n/a
7	chr12:29936486-29936536	SK-N-SH_RA	brain:	n/a
8	chr12:29938317-29938367	BE2_C	brain:	n/a
9	chr12:29936125-29936175	AG09309	skin:	n/a
10	chr12:29936407-29936457	NT2-D1	testis:	n/a
11	chr12:29937585-29937635	ovcar-3	ovarian:	n/a
12	chr12:29936486-29936536	HCT-116	colon:	n/a
13	chr12:29937343-29937393	HCPEpiC	choroid plexus:	n/a
14	chr12:29937585-29937635	HIPEpiC	eye:	n/a
15	chr12:29937733-29937783	BE2_C	brain:	n/a
16	chr12:29937343-29937393	AG09319	gingival:	n/a
17	chr12:29936407-29936457	K562	blood:	n/a
18	chr12:29936407-29936457	NH-A	brain:	n/a
19	chr12:29937343-29937393	HRCEpiC	kidney:	n/a
20	chr12:29937343-29937393	GM19239	blood:	n/a
21	chr12:29937188-29937238	HEEpiC	esophagus:	n/a
22	chr12:29936972-29937022	NB4	blood:	n/a
23	chr12:29936125-29936175	SK-N-MC	brain:	n/a
24	chr12:29936174-29936224	PANC-1	pancreas:	n/a
25	chr12:29936174-29936224	NB4	blood:	n/a
26	chr12:29936839-29936889	K562	blood:	n/a
27	chr12:29936407-29936457	GM12878	blood:	n/a
28	chr12:29938317-29938367	HCT-116	colon:	n/a
29	chr12:29937188-29937238	CMK	blood:	n/a
30	chr12:29937733-29937783	ECC-1	luminal epithelium:	n/a
31	chr12:29936972-29937022	LNCaP	prostate:	n/a
32	chr12:29936407-29936457	NHBE	bronchial:	n/a
33	chr12:29936845-29936895	SKMC	muscle:	n/a
34	chr12:29938317-29938367	HIPEpiC	eye:	n/a
35	chr12:29936845-29936895	HNPCEpiC	eye:	n/a
36	chr12:29936972-29937022	IMR90	lung:	fetal
37	chr12:29936407-29936457	Caco-2	colon:	n/a
38	chr12:29937585-29937635	SAEC	small airway:	n/a
39	chr12:29935873-29935923	SKMC	muscle:	n/a
40	chr12:29935411-29935461	AG04450	lung:	fetal
41	chr12:29936845-29936895	GM06990	blood:	n/a
42	chr12:29937585-29937635	ECC-1	luminal epithelium:	n/a
43	chr12:29936075-29936125	RPTEC	kidney:	n/a
44	chr12:29937188-29937238	ProgFib	skin:	n/a
45	chr12:29937585-29937635	NHDF-neo	bronchial:	n/a
46	chr12:29937585-29937635	HUVEC	blood vessel:	n/a
47	chr12:29936972-29937022	BE2_C	brain:	n/a
48	chr12:29937188-29937238	GM19239	blood:	n/a
49	chr12:29938317-29938367	HMEC	breast:	n/a
50	chr12:29936486-29936536	A549	lung:	n/a

No data

Variant related genes	Relation type
TMTC1	TF binding region
TMTC1	CpG island

Extended variants
information (count: 195 )
Associated
traits (count: 59 )

Variant overlapped rSNPs/rCNVs (count:195 , 50 per page) page: 1 2 3 4

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs570575391	chr12:29934604-29934605	Active TSS Bivalent Enhancer Enhancers Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs539192988	chr12:29934638-29934639	Active TSS Bivalent Enhancer Enhancers Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs547970229	chr12:29934642-29934643	Active TSS Bivalent Enhancer Enhancers Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs116850733	chr12:29934688-29934689	Active TSS Bivalent Enhancer Enhancers Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs148131741	chr12:29934700-29934701	Active TSS Bivalent Enhancer Enhancers Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs570536765	chr12:29934755-29934756	Active TSS Bivalent Enhancer Enhancers Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs554653323	chr12:29934759-29934760	Active TSS Bivalent Enhancer Enhancers Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs189807381	chr12:29934789-29934790	Active TSS Bivalent Enhancer Enhancers Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs374515226	chr12:29934835-29934836	Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs141695644	chr12:29934842-29934843	Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs555214682	chr12:29934856-29934857	Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs576933841	chr12:29934928-29934929	Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs61922588	chr12:29934929-29934930	Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
14	rs140308636	chr12:29935008-29935009	Flanking Bivalent TSS/Enh Enhancers Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs375214818	chr12:29935089-29935090	Flanking Bivalent TSS/Enh Enhancers Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs574629108	chr12:29935138-29935139	Flanking Bivalent TSS/Enh Enhancers Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs182120784	chr12:29935182-29935183	Flanking Bivalent TSS/Enh Enhancers Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs542133736	chr12:29935228-29935229	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
19	rs12810794	chr12:29935240-29935241	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
20	rs574677055	chr12:29935306-29935307	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
21	rs187879269	chr12:29935345-29935346	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
22	rs564121289	chr12:29935376-29935377	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
23	rs200022524	chr12:29935394-29935395	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
24	rs374980153	chr12:29935396-29935397	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
25	rs397694944	chr12:29935401-29935402	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
26	rs201686030	chr12:29935402-29935403	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
27	rs142694588	chr12:29935458-29935459	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
28	rs73077491	chr12:29935479-29935480	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
29	rs185825871	chr12:29935545-29935546	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
30	rs7305813	chr12:29935607-29935608	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
31	rs564441546	chr12:29935731-29935732	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
32	rs570030678	chr12:29935844-29935845	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
33	rs537008184	chr12:29935865-29935866	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
34	rs528518197	chr12:29935898-29935899	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
35	rs540435641	chr12:29935917-29935918	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
36	rs1002888	chr12:29936006-29936007	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs570609361	chr12:29936059-29936060	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs557278690	chr12:29936095-29936096	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
39	rs118012339	chr12:29936153-29936154	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
40	rs552868437	chr12:29936154-29936155	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
41	rs574546866	chr12:29936184-29936185	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
42	rs577660697	chr12:29936187-29936188	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
43	rs557249199	chr12:29936263-29936264	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs570293280	chr12:29936279-29936280	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs368059008	chr12:29936280-29936281	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs575610302	chr12:29936298-29936299	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs545809934	chr12:29936307-29936308	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs564109095	chr12:29936338-29936339	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs200488585	chr12:29936426-29936427	Active TSS Flanking Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
50	rs112603144	chr12:29936472-29936473	Active TSS Flanking Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:59)

Disease	PMID	Source
Melanoma	18172304	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Myxofibrosarcoma	16751306	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Wilms tumour	21544195	CNVD
Squamous cell cancer	21044232	CNVD
Acute myeloid leukemia	16864856	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Colorectal cancer	20709793	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Testicular cancer	18059402	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Seminomas	18059402	CNVD
Esophageal cancer	21851588	CNVD
Lung cancer	20668451	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Testicular germ cell tumor	18059402	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Basal cell lymphoma	17053054	CNVD
Chronic lymphocytic leukemia	21670202	CNVD
Ewing''s sarcoma	17952124	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	21858162	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Myelodysplastic syndrome	21251322	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Autism	22495311	CNVD
Cancer	20164919	CNVD
Acute myeloid leukemia	21251322	CNVD
small cell lung cancer	20016488	CNVD
Neurodevelopmental disorder	22521361	CNVD
Breast cancer	21509527	CNVD
Autism	22102821	CNVD
Follicular lymphoma	18703704	CNVD
Lung cancer	18438408	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Breast cancer	17133270	CNVD
Cancer	21129771	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17899364	CNVD
Myelofibrosis	22110671	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:337 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr12:29928800-29934800	Weak transcription	Fetal Muscle Trunk	muscle
2	chr12:29932000-29934800	Weak transcription	Liver	Liver
3	chr12:29932400-29934800	Weak transcription	Ovary	ovary
4	chr12:29932400-29935200	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
5	chr12:29932400-29935200	Weak transcription	Spleen	Spleen
6	chr12:29932800-29935200	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
7	chr12:29933000-29937800	Active TSS	Aorta	Aorta
8	chr12:29933400-29935000	Enhancers	Primary monocytes fromperipheralblood	blood
9	chr12:29933800-29937800	Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
10	chr12:29934000-29934800	Flanking Active TSS	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
11	chr12:29934000-29935000	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
12	chr12:29934000-29935000	Flanking Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain
13	chr12:29934000-29935000	Flanking Active TSS	Hela-S3	cervix
14	chr12:29934000-29935200	Flanking Active TSS	Muscle Satellite Cultured Cells	--
15	chr12:29934000-29935600	Flanking Active TSS	Adipose Nuclei	Adipose
16	chr12:29934000-29936400	Bivalent/Poised TSS	HUES48 Cell Line	embryonic stem cell
17	chr12:29934000-29937800	Active TSS	Duodenum Smooth Muscle	Duodenum
18	chr12:29934000-29937800	Active TSS	Fetal Kidney	kidney
19	chr12:29934000-29937800	Active TSS	NHLF	lung
20	chr12:29934000-29938000	Active TSS	Right Ventricle	heart
21	chr12:29934200-29934800	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
22	chr12:29934200-29934800	Bivalent Enhancer	HUES64 Cell Line	embryonic stem cell
23	chr12:29934200-29934800	Flanking Active TSS	Breast Myoepithelial Primary Cells	Breast
24	chr12:29934200-29934800	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
25	chr12:29934200-29934800	Flanking Active TSS	Psoas Muscle	Psoas
26	chr12:29934200-29934800	Active TSS	NHDF-Ad	bronchial
27	chr12:29934200-29935000	Active TSS	ES-I3 Cell Line	embryonic stem cell
28	chr12:29934200-29935000	Flanking Active TSS	HMEC	breast
29	chr12:29934200-29935200	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
30	chr12:29934200-29935400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
31	chr12:29934200-29935600	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
32	chr12:29934200-29935800	Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
33	chr12:29934200-29937400	Active TSS	Lung	lung
34	chr12:29934200-29937600	Bivalent/Poised TSS	Duodenum Mucosa	Duodenum
35	chr12:29934200-29937600	Active TSS	Rectal Smooth Muscle	rectum
36	chr12:29934200-29937800	Active TSS	IMR90 fetal lung fibroblasts Cell Line	lung
37	chr12:29934400-29934800	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
38	chr12:29934400-29934800	Flanking Active TSS	Cortex derived primary cultured neurospheres	brain
39	chr12:29934400-29934800	Enhancers	Fetal Brain Male	brain
40	chr12:29934400-29934800	Flanking Active TSS	Left Ventricle	heart
41	chr12:29934400-29934800	Enhancers	Rectal Mucosa Donor 31	rectum
42	chr12:29934400-29934800	Flanking Active TSS	HSMM	muscle
43	chr12:29934400-29934800	Bivalent Enhancer	Monocytes-CD14+_RO01746	blood
44	chr12:29934400-29935000	Flanking Active TSS	Colon Smooth Muscle	Colon
45	chr12:29934400-29935200	Flanking Bivalent TSS/Enh	iPS-20b Cell Line	embryonic stem cell
46	chr12:29934400-29935200	Flanking Active TSS	Fetal Heart	heart
47	chr12:29934400-29935400	Flanking Bivalent TSS/Enh	iPS-18 Cell Line	embryonic stem cell
48	chr12:29934400-29935600	Flanking Active TSS	Fetal Adrenal Gland	Adrenal Gland
49	chr12:29934400-29936400	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
50	chr12:29934400-29937600	Active TSS	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links